Graft Failure

Also known as: Transplant failure

DrugDrug NameDrug Description
DB00020SargramostimA modified form of recombinant human granulocyte-macrophage colony stimulating factor used to increase immune cell production after myelosuppressive therapy or bone marrow transplant.
DrugDrug NamePhaseStatusCount
DB00087Alemtuzumab1 / 2Terminated1
DB01073Fludarabine1 / 2Terminated1
DB00864Tacrolimus1 / 2Terminated1
DB06210Eltrombopag2Recruiting1
DB14724Emapalumab2Recruiting1
DB00099Filgrastim2Recruiting1
DB01073Fludarabine2Recruiting1
DB06809Plerixafor2Recruiting1
DB00864Tacrolimus2Active Not Recruiting1
DB06273Tocilizumab2Not Yet Recruiting1
DB09020Bisacodyl2 / 3Terminated1
DB00117Histidine2 / 3Terminated1
DB00864Tacrolimus2 / 3Terminated1
DB00150Tryptophan2 / 3Terminated1
DB03404Hemin3Completed1
DB09153Sodium chloride3Completed1
DB01590Everolimus4Unknown Status1
DB01024Mycophenolic acid4Unknown Status1
DB00635Prednisone4Unknown Status1
DB09462GlycerinNot AvailableCompleted1
DB01024Mycophenolic acidNot AvailableNot Yet Recruiting1
DB00864TacrolimusNot AvailableNot Yet Recruiting1